Muhammad Furqan

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Novartis
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Poseida
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Tempus
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sophia
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BeiGene
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Jazz Pharma
    Date added:
    03/20/2024
    Date updated:
    03/20/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Mirati
    Date added:
    03/20/2024
    Date updated:
    03/20/2024

Pages

Return to Iowa Hematology Oncology Conference: Emphasis on Precision-Guided Management